Lobbying

The Hemophilia Alliance's latest lobbying report covers Q2 2026, at $30K. The four quarters Q4 2025–Q3 2026 total $100K. Its first report covers Q4 2022; the issues it reports most are Insurance and Medicare/Medicaid.

The Hemophilia Alliance

Latest quarter
No record
Q3 2026 · 0 reports
Last 12 months
$100K
Last 4 quarters
vs last quarter
−100.0%
Q3 2026 against the quarter before
First report
Q4 2022
The first quarter a report named it

Lobbying by quarter

The Hemophilia Alliance lobbying by quarter
The Hemophilia Alliance lobbying by quarter
QuarterAmountReports
Q4 2022$40K1
Q1 2023$40K1
Q2 2023$40K1
Q3 2023$40K1
Q4 2023$40K1
Q1 2024$40K1
Q2 2024$40K1
Q3 2024$40K1
Q4 2024$40K1
Q1 2025$40K1
Q2 2025$40K1
Q3 2025$40K1
Q4 2025$40K1
Q1 2026$30K1
Q2 2026$30K1
Q3 2026$00

By issue

  • Insurance$155K · 15 reports
  • Medicare and Medicaid$155K · 15 reports
  • Pharmacy$155K · 15 reports
  • Budget and appropriations$115K · 12 reports

An issue's amount splits each report's amount equally over the issues the report lists.

Who was lobbied

  • Centers For Medicare and Medicaid Services (CMS)15 reports
  • Health & Human Services, Dept of (HHS)15 reports
  • HOUSE OF REPRESENTATIVES15 reports
  • SENATE15 reports
  • Treasury, Dept of9 reports
  • Health Resources & Services Administration (HRSA)7 reports
  • Food & Drug Administration (FDA)6 reports
  • Natl Institutes of Health (NIH)6 reports
  • Federal Trade Commission (FTC)5 reports
  • Labor, Dept of (DOL)4 reports
  • White House Office3 reports

Firms it paid

Firm
Artemis Policy Group$580K15 quarters

Former officials lobbying for it

Former position
JOHANNA GRAYIntern, Senator Barack ObamaQ2 2026

Lobbying reports

Filed by
07/20for Q2Artemis Policy Group$30K
04/20for Q1Artemis Policy Group$30K
01/20for Q4 2025Artemis Policy Group$40K
25/10/20for Q3 2025Artemis Policy Group$40K
25/07/18for Q2 2025Artemis Policy Group$40K
25/04/21for Q1 2025Artemis Policy Group$40K
25/01/20for Q4 2024Artemis Policy Group$40K
24/10/18for Q3 2024Artemis Policy Group$40K
24/07/22for Q2 2024Artemis Policy Group$40K
24/04/22for Q1 2024Artemis Policy Group$40K
24/01/22for Q4 2023Artemis Policy Group$40K
23/10/20for Q3 2023Artemis Policy Group$40K
23/07/19for Q2 2023Artemis Policy Group$40K
23/04/20for Q1 2023Artemis Policy Group$40K
23/01/20for Q4 2022Artemis Policy Group$40K